UGN-103

PRINCETON, N.J., July 15, 2026 UroGen Pharma announced that the U.S. Patent and Trademark Office (USPTO) has issued a...

PRINCETON, N.J., May 15, 2026 UroGen Pharma Ltd. announced positive six-month results from the ongoing Phase 3 UTOPIA trial,...